The lingering mysteries of metastatic recurrence in breast cancer

AI Riggio, KE Varley, AL Welm - British journal of cancer, 2021 - nature.com
Despite being the hallmark of cancer that is responsible for the highest number of deaths,
very little is known about the biology of metastasis. Metastatic disease typically manifests …

Liquid biopsy at the frontier of detection, prognosis and progression monitoring in colorectal cancer

H Zhou, L Zhu, J Song, G Wang, P Li, W Li, P Luo… - Molecular cancer, 2022 - Springer
Colorectal cancer (CRC) is one of the most common cancers worldwide and a leading
cause of carcinogenic death. To date, surgical resection is regarded as the gold standard by …

Clinical application and detection techniques of liquid biopsy in gastric cancer

S Ma, M Zhou, Y Xu, X Gu, M Zou, G Abudushalamu… - Molecular Cancer, 2023 - Springer
Gastric cancer (GC) is one of the most common tumors worldwide and the leading cause of
tumor-related mortality. Endoscopy and serological tumor marker testing are currently the …

Cancer progression and the invisible phase of metastatic colonization

CA Klein - Nature Reviews Cancer, 2020 - nature.com
Metastatic dissemination occurs very early in the malignant progression of a cancer but the
clinical manifestation of metastases often takes years. In recent decades, 5-year survival of …

Liquid biopsy and minimal residual disease—latest advances and implications for cure

K Pantel, C Alix-Panabières - Nature Reviews Clinical Oncology, 2019 - nature.com
Liquid biopsy has been introduced as a new diagnostic concept predicated on the analysis
of circulating tumour cells (CTCs) or circulating tumour-derived factors, in particular, cell-free …

Recent advances of small extracellular vesicle biomarkers in breast cancer diagnosis and prognosis

Y Lee, J Ni, J Beretov, VC Wasinger, P Graham, Y Li - Molecular cancer, 2023 - Springer
Current clinical tools for breast cancer (BC) diagnosis are insufficient but liquid biopsy of
different bodily fluids has recently emerged as a minimally invasive strategy that provides a …

The incidence of breast cancer recurrence 10-32 years after primary diagnosis

RN Pedersen, BÖ Esen, L Mellemkjær… - JNCI: Journal of the …, 2022 - academic.oup.com
Background Extended, more effective breast cancer treatments have increased the
prevalence of long-term survivors. We investigated the risk of late breast cancer recurrence …

Epithelial-to-mesenchymal transition in cancer: complexity and opportunities

Y Zhang, RA Weinberg - Frontiers of medicine, 2018 - Springer
The cell-biological program termed the epithelial-to-mesenchymal transition (EMT) plays an
important role in both development and cancer progression. Depending on the contextual …

Clinical applications of circulating tumor cells and circulating tumor DNA as liquid biopsy

C Alix-Panabières, K Pantel - Cancer discovery, 2016 - AACR
Abstract “Liquid biopsy” focusing on the analysis of circulating tumor cells (CTC) and
circulating cell-free tumor DNA (ctDNA) in the blood of patients with cancer has received …

High-metastatic cancer cells derived exosomal miR92a-3p promotes epithelial-mesenchymal transition and metastasis of low-metastatic cancer cells by regulating …

B Yang, X Feng, H Liu, R Tong, J Wu, C Li, H Yu… - Oncogene, 2020 - nature.com
Exosomes play an important role in intercellular communication and metastatic progression
of hepatocellular carcinoma (HCC). However, cellular communication between …